2024 |
Viking Therapeutics Inc
|
Independent Director |
433.3 K |
155.9 % |
2024 |
OmniAb Inc
|
President, Chief Executive Officer and Director |
- |
- |
2023 |
Viking Therapeutics Inc
|
Independent Director |
169.4 K |
56.5 % |
2022 |
Viking Therapeutics Inc
|
Independent Director |
108.2 K |
-12.5 % |
2022 |
OmniAb Inc - Warrants (01/11/2027)
|
President, Chief Executive Officer and Director |
- |
- |
2022 |
OmniAb Inc
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
Viking Therapeutics Inc
|
Director |
123.6 K |
-18.7 % |
2021 |
OmniAb Inc
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
Qualigen Therapeutics Inc
|
Director |
- |
- |
2020 |
Viking Therapeutics Inc
|
Director |
152.0 K |
-4.4 % |
2020 |
Qualigen Therapeutics Inc
|
Director |
- |
- |
2019 |
Viking Therapeutics Inc
|
Director |
159.1 K |
94.4 % |
2018 |
Viking Therapeutics Inc
|
Director |
81.8 K |
76.1 % |
2017 |
Viking Therapeutics Inc
|
Director |
46.4 K |
-32.9 % |
2016 |
Viking Therapeutics Inc
|
Director |
69.3 K |
-49.7 % |
2015 |
Viking Therapeutics Inc
|
Director |
137.7 K |
- |
2013 |
Viking Therapeutics Inc
|
Director |
- |
- |